O n March 28, 2011, the AOAC Board of Directors approved an alternative path to achieve Offi cial First Action status for methods selected and reviewed using the AOAC volunteer consensus standards development processes. Under this path, an Expert Review Panel (ERP) vetted by the Offi cial Methods Board selected the method, "Determination of Vitamin A in Infant Formula and Adult Nutritionals by UPLC-UV" for Offi cial First Action status. Methods approved First Action under the alternative path will remain First Action for a period of about 2 years. During this time, methods will be used in laboratories, generating additional information. ERPs will monitor the performance of methods; after about 2 years, they will determine whether the method should be recommended to the Offi cial Methods Board for Final Action.
All methods were reviewed by a primary and secondary expert reviewer. Panel members summarized their reviews, along with the advantages and disadvantages of each method, which were then discussed thoroughly by the entire panel, stakeholders, and observers present. Methods were evaluated for completeness of validation and likelihood of meeting standard method performance requirements (SMPRs), which include appropriateness for the intended use, clarity of the method description, ruggedness, reproducibility, recovery, analytical range, and LOQ.
In November 2010, the Working Group on Vitamin A, chaired by Jonathan DeVries of General Mills/Medallion Laboratories (Minneapolis, MN), recommended the method submitted by Nestlé Research Center (Lausanne, Switzerland) which was approved in June 2011 by the ERP at the "Standards Development and International Harmonization: AOAC INTERNATIONAL Mid-Year Meeting" as AOAC Offi cial Method SM 2011.07. The method uses alcoholic saponifi cation with potassium hydroxide in the presence of antioxidants to convert retinol esters to retinol; diatomaceous earth cartridges to extract, clean, and concentrate the saponifi ed sample; and normal-phase chromatography with UV detection to separate, detect, and quantitate retinol. To move from First to Final Action status, it was recommended that additional information be generated for all types of infant formulas and adult nutritionals at varied concentration levels as indicated in the SMPRs.
AOAC Offi cial Method 2011.07 Vitamin A in Infant Formula and Adult Nutritionals

UPLC-UV First Action 2011
[Applicable to the determination of vitamin A (retinol) in infant formula and adult nutritionals Vitamin A is defi ned as the sum of all-trans retinol, 13-cis retinol, and retinol esters.]
See Tables 2011.07A -D for method performance data supporting acceptance of the method. Caution: Potassium hydroxide is extremely corrosive. Avoid any contact with eyes and skin. Wear laboratory safety goggles. Perform work in a fume hood when using solvents. Refer to Material Safety Data Sheets (MSDS) for specifi c information.
A. Principle
The method uses an alcoholic saponifi cation with potassium hydroxide in the presence of antioxidants to saponify vitamin A to retinol in test samples. The extraction uses solid-phase extraction with a diatomaceous earth cartridge followed by elution with n-hexane. The extract is then evaporated to dryness and diluted in n-hexane. Retinol is then analyzed by UPLC with UV detection at 326 nm and quantitated by comparing the peak heights or peak area of retinol in the test samples with the peak heights or peak areas of external standards. 
D. Preparation of Reagents
Note: Volumes of glassware are purely indicative and may be modifi ed as long as the proportion of reagents is maintained. 
F. Preparation of Test Portions and Solutions
Note: QC samples (certifi ed reference materials, in-house reference samples, or spiked samples) must be regularly included and analyzed in duplicate.
If necessary, different sized glassware may be substituted for specifi c volumes listed during the preparation of test solutions as long as the proper dilution ratios are maintained. (2) Add antioxidant mix (1 g sodium sulfi de, 1 g sodium ascorbate). Note: 1 g sodium ascorbate can be replaced with 0.5 g pyrogallol. Hydroquinone (0.5 g) can also be used as an antioxidant instead of sodium sulfi de and sodium ascorbate mixture.
(3) Add 7 g potassium hydroxide puriss. (2) Transfer quantitatively into a 100 mL amber glass volumetric fl ask.
(3) Add 2 g sodium 1-pentanesulfonate and make up to the mark with water.
(4) Shake well for 1 min. Note: Sodium 1-pentanesulfonate is expensive and can be replaced by 1.5 g sodium dodecyl sulfate which is much cheaper and less soluble. In principle it is easier to use as aqueous solution (1.5 g sodium dodecyl sulfate in 3.5 mL water). (5) Prepare cartridge by fi tting a needle to the Luer connection at the lower end of the cartridge.
(6) Fix the latter by means of a clamp. Note: Too coarse granulometry of the fi lling material will reduce the extraction recovery. Particle size should not be larger than 0.4 mm diameter.
(7) Pipet 20 mL saponifi ed solution on the top of the cartridge. Start again with 15 mL and another cartridge if the solution is not completely retained by the packing as the solution must be completely retained by the packing. Note: It is also possible to mix the Chromabond XTR fi lling material in a beaker with 20 mL hydrolysate with a glass rod and then transfer it into an empty cartridge. This improves the dispersion and absorption of the liquid throughout the fi lling material. In this case, it is not necessary to wait 15 min before starting the elution step.
(c) Elution.
- (1) Elute with 100 mL n-hexane with BHT after 15 min.
(2) Collect eluate into a 250 mL pointed-bottom amber glass fl ask.
(3) Stop elution once all n-hexane has eluted, but no later than 30 min after all the n-hexane has been absorbed by the cartridge fi lling material (packing).
Note: In some cases the saponifi ed sample solution is not completely retained by the extraction cartridge even when using 15 mL instead of 20 mL. The problem may be solved by using a smaller quantity of potassium hydroxide during saponifi cation, e.g., 4 g instead of 7 g or by adding 1 g potassium dihydrogen phosphate to the 20 mL saponifi ed sample solution before loading the extraction cartridge.
(d) Evaporation.-Evaporate solvent under reduced pressure at 30-40°C. Apply a nitrogen stream to evaporate the last few milliliters. Transfer residue quantitatively into a 5 mL amber glass volumetric fl ask by means of small portions of n-hexane. Make up to the mark with n-hexane. Filter through a 0.22 μm membrane fi lter (solution is ready to be injected in the UPLC system). Perform further dilutions in n-hexane to be within the calibration ranges (retinol 0.6-3.0 μg/mL) if needed.
(1) Chromatography.-(a) Chromatographic conditions.-See Table 2011 .07E.
(b) Instrument check test.-Allow the chromatographic system to equilibrate for at least 15 min for UPLC before injecting standards and samples. Make sure the system pressure is stable and there are no leaks. Inject the lowest point of the calibration curve at least three times and ensure the stability of the system, repeatable response, and retention time before starting a series of analyses. Note: Coeffi cients of variation should not be higher than 2% for retention time and peak response. .07A and B) . (12) Allow the phases to separate by letting the mixture stand. Remove the lower layer with a Pasteur pipet.
(13) Add about 0.5 g anhydrous sodium sulfate. (14) Swirl and fi lter into a 100 mL amber glass volumetric fl ask.
(15) Rinse the tube with two portions of about 10 mL n-hexane.
(16) Dilute to the mark with n-hexane.
Reference: J. AOAC Int. in press(2012)
Results and Discussion
Because approval of this method was achieved under the alternative pathway, approved by the AOAC Board of Directors, the method will remain First Action for approximately 2 years while additional information is generated and laboratories have the opportunity to use the method.
The data provided below were generated during profi ciency testing. Using a 10 g test portion, vitamin A can be accurately quantifi ed (LOQ) at 30 μg/100 g. Table 2011 . Based on the results given, the recovery for vitamin A was over 100% for milk-based infant formula. Also notable is that the reproducibility was larger, showing higher betweenlaboratory than within-laboratory variability.
LOQ
LOQ is the limit at which the analyte can be detected.
Precision
In Table 2011 .07A the repeatability and intermediate reproducibility (within-laboratory variability) were estimated by replicate analysis (n r ) on different days (n d ).
Trueness/Recovery
Analysis of internal reference samples. 
Measurement Uncertainty
Measurement uncertainty is estimated using the simplifi ed approach based on existing validation data purposed by Barwick and Ellison (1) . The studies were mainly precision and trueness which, if properly planned to cover as many of the uncertainty sources previously identifi ed as possible, provide the necessary data required to calculate measurement uncertainty. Precision and trueness are combined together in Table 2011 .07D to obtain the overall uncertainty. As seen in Table 2011 .07D, the profi ciency samples yield expanded uncertainly for retinol at 11.6% for milk-based infant formula.
